Published guidance, NICE advice and quality standards | Guidance

Showing 731 to 740 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Infliximab and adalimumab for the treatment of Crohn's disease	TA187	19 May 2010	19 May 2010
Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes	TA47	5 September 2002	1 March 2010
Topotecan for the treatment of relapsed small-cell lung cancer	TA184	25 November 2009	25 November 2009
Topotecan for the treatment of recurrent and stage IVB cervical cancer	TA183	28 October 2009	28 October 2009
Guidance on the use of electroconvulsive therapy	TA59	26 April 2003	1 October 2009
Sunitinib for the treatment of gastrointestinal stromal tumours	TA179	23 September 2009	23 September 2009
Pemetrexed for the first-line treatment of non-small-cell lung cancer	TA181	23 September 2009	23 September 2009
Alitretinoin for the treatment of severe chronic hand eczema	TA177	26 August 2009	26 August 2009
Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinoma	TA178	26 August 2009	26 August 2009
Tenofovir disoproxil for the treatment of chronic hepatitis B	TA173	22 July 2009	22 July 2009